Product NDC: | 45802-660 |
Proprietary Name: | Clindamycin Phosphate |
Non Proprietary Name: | clindamycin phosphate |
Active Ingredient(s): | 10 mg/g & nbsp; clindamycin phosphate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | AEROSOL, FOAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 45802-660 |
Labeler Name: | Perrigo New York Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090785 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100331 |
Package NDC: | 45802-660-32 |
Package Description: | 1 CAN in 1 CARTON (45802-660-32) > 50 g in 1 CAN |
NDC Code | 45802-660-32 |
Proprietary Name | Clindamycin Phosphate |
Package Description | 1 CAN in 1 CARTON (45802-660-32) > 50 g in 1 CAN |
Product NDC | 45802-660 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | clindamycin phosphate |
Dosage Form Name | AEROSOL, FOAM |
Route Name | TOPICAL |
Start Marketing Date | 20100331 |
Marketing Category Name | ANDA |
Labeler Name | Perrigo New York Inc |
Substance Name | CLINDAMYCIN PHOSPHATE |
Strength Number | 10 |
Strength Unit | mg/g |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |